Clinical trial

Real-World Case Registry Study on Obesity

Recruiting now · Not applicable · 1 countries · Registry ID NCT07448090

Recruiting nowNot applicableObservational

What this study is about

Obesity is a major risk factor for cardiovascular disease, diabetes, cancer, and other chronic conditions. Due to its complex etiology and frequent comorbidities, effective obesity management requires comprehensive and individualized approaches. This study is a multicenter, prospective, real-world registry designed to evaluate integrated traditional Chinese medicine (TCM) and Western medicine interventions for obesity. The study will enroll at least 10,000 individuals with obesity from urban and rural populations. Multimodal data, including electronic medical records, laboratory test results, imaging data, and lifestyle information, will be collected. The effectiveness of integrated TCM and Western medicine interventions will be assessed across different age groups, disease stages, and obesity-related constitution types. In addition, disease progression patterns and key prevention and treatment points will be explored. Health economic analyses will be conducted to evaluate the cost-effectiveness of different obesity management strategies, providing real-world evidence to support public health policy and the optimization of integrated obesity prevention and management approaches.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to 75 Years

SexAll

Healthy volunteersNot accepted

ConditionObesity & Overweight, Obesity (Disorder)

Full registry criteria

Inclusion Criteria: 1. Age 18 years and above, gender not restricted; 2. Weight fluctuation within the last 3 months is ≤ 5% and BMI is ≥ 28.0 kg/m2; 3. Good compliance, willing to follow the follow-up principles; 4. Agree to sign the informed consent form. Exclusion Criteria: 1. Co-existing severe diseases of the heart, liver, lungs, kidneys, brain, blood, neuro-psychiatric system, or other vital organs. 2. Secondary obesity (obesity attributable to another clearly diagnosed disorder, e.g., hypothalamic or pituitary inflammation, tumours or trauma, Cushing's syndrome, hypothyroidism, hypogonadism, polycystic ovary syndrome, etc.). 3. Iatrogenic obesity (obesity resulting from drugs or therapeutic interventions administered for other conditions). 4. Pregnant or lactating women. 5. Subjects whom the investigator deems unsuitable for participation in this study.

Treatments and study arms

The registry does not list a named intervention.

Primary outcomes

Percentage reduction in body weight relative to baselineBaseline, 12 weeks after treatment, 24 weeks after treatment

Percentage change in body weight from baseline to 12 weeks and 24 weeks after treatment, calculated as \[(body weight at each follow-up time point - baseline body weight) / baseline body weight\] × 100%.

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Hubei Provincial Hospital of Traditional Chinese Medicine🇨🇳 Wuhan, Hubei, China

Open map

Zhuhui Zhuhui, DoctorContact

Email · Call 13545094802